Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza.
The European Center for Disease Prevention and Control recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Influenza Vaccine market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Influenza Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Influenza Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Shijiazhuang Yiling Pharmaceutical
Moderna Therapeutics
SK Chemicals
Sanofi
CSL
Green Cross
Novavax
AstraZeneca
Folia Biotech
Vaccitec
Medicago
UNM Pharma
Altimmune
Genentech
FluGen
BionVax
GlaxoSmithKline
By Type:
Fluzone/Vaxigrip
FluMist
Fluarix and Flulaval
Anflu
Fluvax/Afluria
Flucelvax and Fluvirin
By End-User:
Adults
Pediatrics
Senior Citizens
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenza Vaccine Market
-
1.3 Market Segment by Type
-
1.3.1 USA Influenza Vaccine Market Size and Growth Rate of Fluzone/Vaxigrip from 2016 to 2027
-
1.3.2 USA Influenza Vaccine Market Size and Growth Rate of FluMist from 2016 to 2027
-
1.3.3 USA Influenza Vaccine Market Size and Growth Rate of Fluarix and Flulaval from 2016 to 2027
-
1.3.4 USA Influenza Vaccine Market Size and Growth Rate of Anflu from 2016 to 2027
-
1.3.5 USA Influenza Vaccine Market Size and Growth Rate of Fluvax/Afluria from 2016 to 2027
-
1.3.6 USA Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Influenza Vaccine Market Size and Growth Rate of Adults from 2016 to 2027
-
1.4.2 USA Influenza Vaccine Market Size and Growth Rate of Pediatrics from 2016 to 2027
-
1.4.3 USA Influenza Vaccine Market Size and Growth Rate of Senior Citizens from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Influenza Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Influenza Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Influenza Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Influenza Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Influenza Vaccine Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Influenza Vaccine by Major Types
-
3.4.1 Market Size and Growth Rate of Fluzone/Vaxigrip
-
3.4.2 Market Size and Growth Rate of FluMist
-
3.4.3 Market Size and Growth Rate of Fluarix and Flulaval
-
3.4.4 Market Size and Growth Rate of Anflu
-
3.4.5 Market Size and Growth Rate of Fluvax/Afluria
-
3.4.6 Market Size and Growth Rate of Flucelvax and Fluvirin
4 Segmentation of Influenza Vaccine Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Influenza Vaccine by Major End-Users
-
4.4.1 Market Size and Growth Rate of Influenza Vaccine in Adults
-
4.4.2 Market Size and Growth Rate of Influenza Vaccine in Pediatrics
-
4.4.3 Market Size and Growth Rate of Influenza Vaccine in Senior Citizens
5 Market Analysis by Regions
-
5.1 USA Influenza Vaccine Production Analysis by Regions
-
5.2 USA Influenza Vaccine Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Influenza Vaccine Landscape Analysis
-
6.1 West USA Influenza Vaccine Landscape Analysis by Major Types
-
6.2 West USA Influenza Vaccine Landscape Analysis by Major End-Users
7 South USA Influenza Vaccine Landscape Analysis
-
7.1 South USA Influenza Vaccine Landscape Analysis by Major Types
-
7.2 South USA Influenza Vaccine Landscape Analysis by Major End-Users
8 Middle West USA Influenza Vaccine Landscape Analysis
-
8.1 Middle West USA Influenza Vaccine Landscape Analysis by Major Types
-
8.2 Middle West USA Influenza Vaccine Landscape Analysis by Major End-Users
9 Northeast USA Influenza Vaccine Landscape Analysis
-
9.1 Northeast USA Influenza Vaccine Landscape Analysis by Major Types
-
9.2 Northeast USA Influenza Vaccine Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Shijiazhuang Yiling Pharmaceutical
-
10.1.1 Shijiazhuang Yiling Pharmaceutical Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Moderna Therapeutics
-
10.2.1 Moderna Therapeutics Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 SK Chemicals
-
10.3.1 SK Chemicals Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Sanofi
-
10.4.1 Sanofi Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 CSL
-
10.5.1 CSL Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Green Cross
-
10.6.1 Green Cross Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Novavax
-
10.7.1 Novavax Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 AstraZeneca
-
10.8.1 AstraZeneca Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Folia Biotech
-
10.9.1 Folia Biotech Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Vaccitec
-
10.10.1 Vaccitec Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Medicago
-
10.11.1 Medicago Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 UNM Pharma
-
10.12.1 UNM Pharma Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Altimmune
-
10.13.1 Altimmune Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Genentech
-
10.14.1 Genentech Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 FluGen
-
10.15.1 FluGen Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 BionVax
-
10.16.1 BionVax Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
-
10.17 GlaxoSmithKline
-
10.17.1 GlaxoSmithKline Company Profile and Recent Development
-
10.17.2 Market Performance
-
10.17.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Influenza Vaccine Market Size and Growth Rate of Fluzone/Vaxigrip from 2016 to 2027
-
Figure USA Influenza Vaccine Market Size and Growth Rate of FluMist from 2016 to 2027
-
Figure USA Influenza Vaccine Market Size and Growth Rate of Fluarix and Flulaval from 2016 to 2027
-
Figure USA Influenza Vaccine Market Size and Growth Rate of Anflu from 2016 to 2027
-
Figure USA Influenza Vaccine Market Size and Growth Rate of Fluvax/Afluria from 2016 to 2027
-
Figure USA Influenza Vaccine Market Size and Growth Rate of Flucelvax and Fluvirin from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Influenza Vaccine Market Size and Growth Rate of Adults from 2016 to 2027
-
Figure USA Influenza Vaccine Market Size and Growth Rate of Pediatrics from 2016 to 2027
-
Figure USA Influenza Vaccine Market Size and Growth Rate of Senior Citizens from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Influenza Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Influenza Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Influenza Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Influenza Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Influenza Vaccine Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Influenza Vaccine
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Influenza Vaccine by Different Types from 2016 to 2027
-
Table Consumption Share of Influenza Vaccine by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Fluzone/Vaxigrip
-
Figure Market Size and Growth Rate of FluMist
-
Figure Market Size and Growth Rate of Fluarix and Flulaval
-
Figure Market Size and Growth Rate of Anflu
-
Figure Market Size and Growth Rate of Fluvax/Afluria
-
Figure Market Size and Growth Rate of Flucelvax and Fluvirin
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Influenza Vaccine by Different End-Users from 2016 to 2027
-
Table Consumption Share of Influenza Vaccine by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Adults
-
Figure Market Size and Growth Rate of Pediatrics
-
Figure Market Size and Growth Rate of Senior Citizens
-
Table USA Influenza Vaccine Production by Regions
-
Table USA Influenza Vaccine Production Share by Regions
-
Figure USA Influenza Vaccine Production Share by Regions in 2016
-
Figure USA Influenza Vaccine Production Share by Regions in 2021
-
Figure USA Influenza Vaccine Production Share by Regions in 2027
-
Table USA Influenza Vaccine Consumption by Regions
-
Table USA Influenza Vaccine Consumption Share by Regions
-
Figure USA Influenza Vaccine Consumption Share by Regions in 2016
-
Figure USA Influenza Vaccine Consumption Share by Regions in 2021
-
Figure USA Influenza Vaccine Consumption Share by Regions in 2027
-
Table West USA Influenza Vaccine Consumption by Types from 2016 to 2027
-
Table West USA Influenza Vaccine Consumption Share by Types from 2016 to 2027
-
Figure West USA Influenza Vaccine Consumption Share by Types in 2016
-
Figure West USA Influenza Vaccine Consumption Share by Types in 2021
-
Figure West USA Influenza Vaccine Consumption Share by Types in 2027
-
Table West USA Influenza Vaccine Consumption by End-Users from 2016 to 2027
-
Table West USA Influenza Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Influenza Vaccine Consumption Share by End-Users in 2016
-
Figure West USA Influenza Vaccine Consumption Share by End-Users in 2021
-
Figure West USA Influenza Vaccine Consumption Share by End-Users in 2027
-
Table South USA Influenza Vaccine Consumption by Types from 2016 to 2027
-
Table South USA Influenza Vaccine Consumption Share by Types from 2016 to 2027
-
Figure South USA Influenza Vaccine Consumption Share by Types in 2016
-
Figure South USA Influenza Vaccine Consumption Share by Types in 2021
-
Figure South USA Influenza Vaccine Consumption Share by Types in 2027
-
Table South USA Influenza Vaccine Consumption by End-Users from 2016 to 2027
-
Table South USA Influenza Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Influenza Vaccine Consumption Share by End-Users in 2016
-
Figure South USA Influenza Vaccine Consumption Share by End-Users in 2021
-
Figure South USA Influenza Vaccine Consumption Share by End-Users in 2027
-
Table Middle West USA Influenza Vaccine Consumption by Types from 2016 to 2027
-
Table Middle West USA Influenza Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Influenza Vaccine Consumption Share by Types in 2016
-
Figure Middle West USA Influenza Vaccine Consumption Share by Types in 2021
-
Figure Middle West USA Influenza Vaccine Consumption Share by Types in 2027
-
Table Middle West USA Influenza Vaccine Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Influenza Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Influenza Vaccine Consumption Share by End-Users in 2016
-
Figure Middle West USA Influenza Vaccine Consumption Share by End-Users in 2021
-
Figure Middle West USA Influenza Vaccine Consumption Share by End-Users in 2027
-
Table Northeast USA Influenza Vaccine Consumption by Types from 2016 to 2027
-
Table Northeast USA Influenza Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Influenza Vaccine Consumption Share by Types in 2016
-
Figure Northeast USA Influenza Vaccine Consumption Share by Types in 2021
-
Figure Northeast USA Influenza Vaccine Consumption Share by Types in 2027
-
Table Northeast USA Influenza Vaccine Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Influenza Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Influenza Vaccine Consumption Share by End-Users in 2016
-
Figure Northeast USA Influenza Vaccine Consumption Share by End-Users in 2021
-
Figure Northeast USA Influenza Vaccine Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Shijiazhuang Yiling Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shijiazhuang Yiling Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Shijiazhuang Yiling Pharmaceutical
-
Figure Revenue and Market Share Analysis of Shijiazhuang Yiling Pharmaceutical
-
Table Product and Service Introduction of Shijiazhuang Yiling Pharmaceutical
-
Table Company Profile and Development Status of Moderna Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics
-
Figure Sales and Growth Rate Analysis of Moderna Therapeutics
-
Figure Revenue and Market Share Analysis of Moderna Therapeutics
-
Table Product and Service Introduction of Moderna Therapeutics
-
Table Company Profile and Development Status of SK Chemicals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of SK Chemicals
-
Figure Sales and Growth Rate Analysis of SK Chemicals
-
Figure Revenue and Market Share Analysis of SK Chemicals
-
Table Product and Service Introduction of SK Chemicals
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of CSL
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL
-
Figure Sales and Growth Rate Analysis of CSL
-
Figure Revenue and Market Share Analysis of CSL
-
Table Product and Service Introduction of CSL
-
Table Company Profile and Development Status of Green Cross
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Green Cross
-
Figure Sales and Growth Rate Analysis of Green Cross
-
Figure Revenue and Market Share Analysis of Green Cross
-
Table Product and Service Introduction of Green Cross
-
Table Company Profile and Development Status of Novavax
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax
-
Figure Sales and Growth Rate Analysis of Novavax
-
Figure Revenue and Market Share Analysis of Novavax
-
Table Product and Service Introduction of Novavax
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Folia Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Folia Biotech
-
Figure Sales and Growth Rate Analysis of Folia Biotech
-
Figure Revenue and Market Share Analysis of Folia Biotech
-
Table Product and Service Introduction of Folia Biotech
-
Table Company Profile and Development Status of Vaccitec
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaccitec
-
Figure Sales and Growth Rate Analysis of Vaccitec
-
Figure Revenue and Market Share Analysis of Vaccitec
-
Table Product and Service Introduction of Vaccitec
-
Table Company Profile and Development Status of Medicago
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medicago
-
Figure Sales and Growth Rate Analysis of Medicago
-
Figure Revenue and Market Share Analysis of Medicago
-
Table Product and Service Introduction of Medicago
-
Table Company Profile and Development Status of UNM Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of UNM Pharma
-
Figure Sales and Growth Rate Analysis of UNM Pharma
-
Figure Revenue and Market Share Analysis of UNM Pharma
-
Table Product and Service Introduction of UNM Pharma
-
Table Company Profile and Development Status of Altimmune
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altimmune
-
Figure Sales and Growth Rate Analysis of Altimmune
-
Figure Revenue and Market Share Analysis of Altimmune
-
Table Product and Service Introduction of Altimmune
-
Table Company Profile and Development Status of Genentech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech
-
Figure Sales and Growth Rate Analysis of Genentech
-
Figure Revenue and Market Share Analysis of Genentech
-
Table Product and Service Introduction of Genentech
-
Table Company Profile and Development Status of FluGen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of FluGen
-
Figure Sales and Growth Rate Analysis of FluGen
-
Figure Revenue and Market Share Analysis of FluGen
-
Table Product and Service Introduction of FluGen
-
Table Company Profile and Development Status of BionVax
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BionVax
-
Figure Sales and Growth Rate Analysis of BionVax
-
Figure Revenue and Market Share Analysis of BionVax
-
Table Product and Service Introduction of BionVax
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
